Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AB Science S.A (PA: AB)

 
AB Technical Analysis
5
As on 9th Jun 2023 AB SHARE Price closed @ 4.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.00 & Strong Sell for SHORT-TERM with Stoploss of 9.88 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABSHARE Price

Open 4.50 Change Price %
High 4.50 1 Day -0.19 -4.27
Low 4.25 1 Week 0.12 2.90
Close 4.26 1 Month -2.16 -33.64
Volume 89937 1 Year -7.74 -64.50
52 Week High 12.53 | 52 Week Low 4.09
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
AB
Daily Charts		 AB
Intraday Charts		 Whats New @
Bazaartrend		 AB
Free Analysis
 
AB Important Levels Intraday
RESISTANCE4.74
RESISTANCE4.59
RESISTANCE4.49
RESISTANCE4.40
SUPPORT4.12
SUPPORT4.03
SUPPORT3.93
SUPPORT3.78
 
AB Forecast April 2024
Share
4th UP Forecast12.95
3rd UP Forecast10.16
2nd UP Forecast8.44
1st UP Forecast6.72
1st DOWN Forecast1.8
2nd DOWN Forecast0.08
3rd DOWN Forecast-1.64
4th DOWN Forecast-4.43
 
AB Weekly Forecast
4th UP Forecast5.94
3rd UP Forecast5.40
2nd UP Forecast5.07
1st UP Forecast4.73
1st DOWN Forecast3.79
2nd DOWN Forecast3.45
3rd DOWN Forecast3.12
4th DOWN Forecast2.58
 
AB Forecast2024
4th UP Forecast22.22
3rd UP Forecast16.46
2nd UP Forecast12.9
1st UP Forecast9.34
1st DOWN Forecast-0.82
2nd DOWN Forecast-4.38
3rd DOWN Forecast-7.94
4th DOWN Forecast-13.7
 
 
AB Other Details
Segment EQ
Market Capital 616233280.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AB Address
AB
 
AB Latest News
 
Your Comments and Response on AB Science S.A
 
AB Business Profile
AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. Address: 3, Avenue George V, Paris, France, 75008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service